NCCN Updates ctDNA Stance in Colon, Rectal, and MCC Guidelines
FDA Grants Fast Track Designation to CUSP06 for Platinum-Resistant Ovarian Cancer
Potential Applications of Cancer Vaccines Continue to Expand in Squamous Cell Carcinoma
FDA Approves Brentuximab Vedotin Plus Lenalidomide/Rituximab for R/R LBCL